Thank you, Mr. Chairman.
Mr. Allard, thanks. It's interesting to see you in a different chair today. You've mentioned the PRISMA screening tool, and in fact I questioned Dr. Marshall on that specific thing. He was mentioning to me that there's still some work, and it's going through an evolution. We have the PRISMA that's in the report, but do you have a revised one that you can present to the committee?